1. Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590). Issue 23 (7th August 2017) Authors: Bhatia, Aarti K.; Lee, Ju‐Whei; Pinto, Harlan A.; Jacobs, Charlotte D.; Limburg, Paul J.; Rubin, Philip; Arusell, Robert M.; Dunphy, Eamonn P.; Khandekar, Janardan D.; Reiner, Seth A.; Baez‐Diaz, Luis; Celano, Paul; Li, Shuli; Li, Yi; Burtness, Barbara A.; Adams, George L.; Pandya, Kishan J. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗